Does RIOCIGUAT Cause Hepatic neoplasm? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hepatic neoplasm have been filed in association with RIOCIGUAT (Adempas). This represents 0.1% of all adverse event reports for RIOCIGUAT.
10
Reports of Hepatic neoplasm with RIOCIGUAT
0.1%
of all RIOCIGUAT reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hepatic neoplasm From RIOCIGUAT?
Of the 10 reports, 5 (50.0%) required hospitalization.
Is Hepatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIOCIGUAT. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does RIOCIGUAT Cause?
Death (4,500)
Dyspnoea (2,881)
Headache (2,462)
Dizziness (2,208)
Hypotension (2,192)
Nausea (2,020)
Hospitalisation (1,864)
Diarrhoea (1,790)
Fatigue (1,638)
Vomiting (1,124)
What Other Drugs Cause Hepatic neoplasm?
OCTREOTIDE (300)
ADALIMUMAB (98)
LANREOTIDE (85)
EVEROLIMUS (84)
AMLODIPINE (74)
ROSUVASTATIN (55)
IMATINIB (51)
BEVACIZUMAB (49)
RIBAVIRIN (49)
METFORMIN (47)
Which RIOCIGUAT Alternatives Have Lower Hepatic neoplasm Risk?
RIOCIGUAT vs RIPRETINIB
RIOCIGUAT vs RISANKIZUMAB
RIOCIGUAT vs RISANKIZUMAB-RZAA
RIOCIGUAT vs RISDIPLAM
RIOCIGUAT vs RISEDRONATE